Drugs / 99mTc-Annexin V-128
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02459613 | Feb 2016 → May 2017 | endocarditis, thrombotic disease | French National Institute of Health and Medical Research | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 99mTc-Annexin V-128 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02459613 ↗ |
| Modality | Diagnostic / imaging agent | “molecular imaging” NCT02459613 ↗ |